U.S., Sept. 6 -- ClinicalTrials.gov registry received information related to the study (NCT07157618) titled 'Prospective Pathology Foundation Models' on Aug. 28.
Brief Summary: Histopathology remains the gold standard for disease diagnosis, yet faces challenges including pathologist shortages and diagnostic model limitations. This underscores the critical need to develop deep learning-based pathology foundation models integrating prospective imaging and clinical data. Such models would enhance diagnostic accuracy and efficiency, enabling tumor grading, histo-molecular classification, and intelligent chemotherapy guidance - ultimately optimizing clinical workflows. However, a critical gap remains: the absence of prospectively validated, pan...